EAS 2020

A novel small binding protein that targets PCSK9
A novel small binding protein that targets PCSK9
EAS 2020
A novel small binding protein that targets PCSK9
- Evan Stein, MD, PhD
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
EAS 2020
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
- Prof. Frederick Raal
Huge advantage with ANGPTL3 inhibitor for HoFH patients with minimal to zero LDLR activity
Huge advantage with ANGPTL3 inhibitor for HoFH patients with minimal to zero LDLR activity
EAS 2020
Huge advantage with ANGPTL3 inhibitor for HoFH patients with minimal to zero LDLR activity
- Prof. Frederick Raal